Globus Medical (GMED) Convertible Debt (2023)
Globus Medical (GMED) posted Convertible Debt of $417.4 million for Q4 2023, up 1.87% on a QoQ basis from $409.7 million in Q3 2023.
Globus Medical (GMED) Convertible Debt (2023) Analysis & Trends
Globus Medical's Convertible Debt history runs 1 years deep, the most recent figure standing at $417.4 million for Q4 2023.
- Quarterly Convertible Debt changed N/A year-over-year to $417.4 million in Q4 2023, while the trailing twelve-month figure through Dec 2023 was $417.4 million (changed N/A YoY) and the FY2023 annual result came in at $417.4 million, changed N/A from the prior year.
- Convertible Debt was $417.4 million for Q4 2023 at Globus Medical, up from $409.7 million in the prior quarter.
- Across five years, Convertible Debt topped out at $417.4 million in Q4 2023 and bottomed at $409.7 million in Q3 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Globus Medical | 10.21 Bn | 9.58 Bn | 525.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 417.40 Mn |
| Sep 30, 2023 | 409.72 Mn |